|

Oxygenix has established a drug discovery network on the basis of technologies developed at Waseda and Keio Universities over the years. This network has made it possible for Oxygenix to add a number of new protein-based drugs to its R&D pipeline.
Oxygenix has established its own business bases in North America and Asia, and comprehensive R&D infrastructure. This constitutes Oxygenix's drug discovery network and is essential for the global development of its unique protein-based liposomal drugs.
Oxygenix continues to expand and upgrade each research center which supports this network and ensures close collaboration between research centers in order to accelerate global drug research and development business. |
|